salmeterol xinafoate has been researched along with Dermatitis, Atopic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corrigan, CJ; Faith, A; Hawrylowicz, CM; Lavender, P; Lee, TH; Peek, EJ; Richards, DF | 1 |
| Grönneberg, R; Halldén, G; Hed, J; Raud, J; van Hage-Hamsten, M | 1 |
1 trial(s) available for salmeterol xinafoate and Dermatitis, Atopic
| Article | Year |
|---|---|
Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopic patients.
Topics: Administration, Cutaneous; Adrenergic beta-Agonists; Adult; Albuterol; Blister; Dermatitis, Atopic; Humans; Middle Aged; Premedication; Rhinitis, Allergic, Seasonal; Salmeterol Xinafoate; Terbutaline | 1996 |
1 other study(ies) available for salmeterol xinafoate and Dermatitis, Atopic
| Article | Year |
|---|---|
Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonists.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Allergens; Androstadienes; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; Cell Line; Cytokines; Dermatitis, Atopic; Dose-Response Relationship, Drug; Female; Fluticasone; Glucocorticoids; Humans; Interferon-gamma; Interleukin-10; Interleukin-13; Interleukin-5; Leukocytes, Mononuclear; Male; Middle Aged; Salmeterol Xinafoate; T-Lymphocytes; Th2 Cells | 2005 |